Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TT223 in type 2 diabetes mellitus treated with metformin and/or TZD
NCT00743002Phase 2Completed
- Sponsor
- OPKO Health
- Start
- Aug 2008
- Primary completion
- Dec 2009
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TT-223 in type 2 diabetes mellitus (T2DM), sponsored by OPKO Health. Started Aug 2008; status: completed.
02
Drugs
TT-223
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00743002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00743002.